Get an in-depth view into the Draft Pharma Policy - MedicinMan does a deep dive with the President of Karnataka Drug and Pharmaceutical Manufacturers Association
Articles by K. Hariram, Pankaj Mehrotra, Rinkesh Shah, Gopal Kishore, Amaninder S. Dhillon, Ramandish Arora, Mohit Kumar Bhutani, Richa Goyal, and Mahendra Kumar Rai
The last issue of 2016, with articles from K. Hariram and Vivek Hattangadi and new authors, Dr. Ashwin Bonde and Diksha Fouzdar. Diksha's article is the highlight of this issue - an in-depth look at how to embed compliance in the very DNA of a pharma company.
The Indian Pharmaceutical Market (IPM) was valued at Rs. 10,278 crs in the month of September 2016 clocking a strong 10% growth over same period last year (SPLY). On a MAT September basis, the industry was valued at Rs. 111,022 crores and reflected a 13% growth with volumes contributing around 40% of this growth and New Introductions playing an important role with around 38% contribution to the overall growth.
Nimesulide Regulatory Status Worldwide
Nimesulide is a non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic use. It has a well-documented...
April 14, 2025
India’s pharmaceutical industry, a global powerhouse, sends affordable medicines to millions of Americans, saving the U.S. healthcare...
KKR's Investments in India's Medical Devices Market: Strategic Implications and Key Investors
Introduction
The Indian medical devices sector is witnessing unprecedented...
India pharma is crucial for global healthcare, providing affordable medicines worldwide.India's pharma companies excel in domestic markets and international...
India's top 10 pharma companies by market capitalization, offering insights into their valuation, revenue performance, and industry trends
In 2025, the Indian...
Introduction
For decades, leaders and organizations have relied on the VUCA framework—Volatility, Uncertainty, Complexity, and Ambiguity—to understand and respond to...